BSE Live
Sep 30, 16:01Prev. Close
1320.00
Open Price
1320.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 30, 15:59Prev. Close
1317.00
Open Price
1329.20
Bid Price (Qty.)
1339.00 (52)
Offer Price (Qty.)
0.00 (0)
Profit & Loss account of Ipca Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 6,639.52 | 6,121.79 | 5,777.18 | 5,336.38 | 5,085.19 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 6,639.52 | 6,121.79 | 5,777.18 | 5,336.38 | 5,085.19 | |
Total Operating Revenues | 6,677.92 | 6,166.46 | 5,814.62 | 5,399.36 | 5,139.16 | |
Other Income | 71.29 | 111.29 | 111.19 | 56.13 | 62.24 | |
Total Revenue | 6,749.21 | 6,277.75 | 5,925.81 | 5,455.49 | 5,201.40 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 1,417.64 | 1,688.36 | 1,684.03 | 1,600.98 | 1,555.53 | |
Purchase Of Stock-In Trade | 347.24 | 345.21 | 280.91 | 282.90 | 197.68 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | 128.43 | -55.19 | 104.09 | -120.76 | -170.73 | |
Employee Benefit Expenses | 1,479.34 | 1,336.19 | 1,193.39 | 1,089.63 | 948.84 | |
Finance Costs | 63.04 | 120.67 | 43.92 | 7.21 | 8.14 | |
Depreciation And Amortisation Expenses | 251.97 | 246.48 | 228.63 | 204.10 | 187.72 | |
Other Expenses | 1,780.24 | 1,640.51 | 1,640.35 | 1,303.07 | 1,094.26 | |
Total Expenses | 5,467.90 | 5,322.23 | 5,175.32 | 4,367.13 | 3,821.44 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1,281.31 | 955.52 | 750.49 | 1,088.36 | 1,379.96 | |
Exceptional Items | -281.54 | -133.36 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 999.77 | 822.16 | 750.49 | 1,088.36 | 1,379.96 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 341.63 | 291.00 | 223.95 | 197.20 | 244.98 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 8.11 | 3.74 | 20.84 | 20.14 | -5.79 | |
Tax For Earlier Years | -0.73 | -2.99 | 0.00 | 0.08 | 0.00 | |
Total Tax Expenses | 349.01 | 291.75 | 244.79 | 217.42 | 239.19 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 650.76 | 530.41 | 505.70 | 870.94 | 1,140.77 | |
Profit/Loss From Continuing Operations | 650.76 | 530.41 | 505.70 | 870.94 | 1,140.77 | |
Profit/Loss For The Period | 650.76 | 530.41 | 505.70 | 870.94 | 1,140.77 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 36.75 | 26.16 | 19.93 | 34.33 | 90.08 | |
Diluted EPS (Rs.) | 25.65 | 20.91 | 19.93 | 34.33 | 90.08 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 101.48 | 50.74 | 101.48 | 101.48 | 101.48 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 400.00 | 400.00 | 400.00 | 400.00 | 400.00 |
05.09.2025
Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y
13.08.2025
Accumulate Ipca Laboratories; target of Rs 1525: Prabhudas Lilladher
10.06.2025
Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y
03.06.2025
Ipca Labs Consolidated March 2025 Net Sales at Rs 2,246.69 crore, up 10.51% Y-o-Y
05.09.2025
Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y
10.06.2025
Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y
03.06.2025
Ipca Labs Consolidated March 2025 Net Sales at Rs 2,246.69 crore, up 10.51% Y-o-Y
04.03.2025
Ipca Labs Consolidated December 2024 Net Sales at Rs 2,245.37 crore, up 9.38% Y-o-Y
13.07.2022
Ipca Lab Q1 PAT may dip 41.4% YoY to Rs 179.8 cr: ICICI Direct
08.07.2022
Ipca Laboratories Q1 PAT may dip 36.5% YoY to Rs 194.9 cr: Prabhudas Lilladher
14.04.2022
Ipca Laboratories Q4 PAT may dip 12% YoY to Rs 141.9 cr: Prabhudas Lilladher
13.01.2022
Ipca Laboratories Q3 PAT may dip 32.4% YoY to Rs 179.6 cr: Prabhudas Lilladher